Videos
Future Research on the Pathogenesis of COVID-19, Cognitive Changes: Joanna Hellmuth, MD, MS
February 8th 2022The cognitive neurologist at the University of California San Francisco discussed the need to continue research on why patients develop cognitive changes following COVID-19 infection and how clinicians can care for them. [WATCH TIME: 4 minutes]
Unmet Needs in the Management of Insomnia
A brief review of the unmet needs in insomnia management, particularly access to treatment and daytime functioning.
Factors in Selecting Pharmacologic Therapy for Insomnia
Practical considerations for selecting a particular agent or class when treating a patient with insomnia.
Optimizing Integrative Wellness Strategies for MS Through Research: Kathy Zackowski, PhD, OTR
February 6th 2022The senior director of patient management, care, and rehabilitation at the National Multiple Sclerosis Society discussed the steps needed to take to improve relatively new wellness strategies. [WATCH TIME: 3 minutes]
Evolving Roles of Women in Neurology: Jan Brandes, MD, MS
February 3rd 2022In light of National Women Physicians Day, the assistant clinical professor at Vanderbilt University School of Medicine commented on the roles women have played historically, and her perspective on where they stand now. [WATCH TIME: 12 minutes]
Importance of National Women Physicians Day and Valuing Women in Neurology: Jan Brandes, MD, MS
February 3rd 2022The assistant clinical professor at Vanderbilt University School of Medicine shared what National Women Physicians Day means to her, and the history behind its celebration. [WATCH TIME: 6 minutes]
Managing MS With Wellness Approaches During COVID-19: Kathy Zackowski, PhD, OTR
February 2nd 2022The senior director of patient management, care, and rehabilitation at the National Multiple Sclerosis Society discussed the importance and flexibility of wellness approaches for patients with MS during the pandemic. [WATCH TIME: 4 minutes]
Updates on the Diagnostics Accelerator, Future Goals of the ADDF: Howard Fillit, MD
February 1st 2022The founding executive director of the Alzheimer’s Drug Discovery Foundation commented on ongoing developments from the organization, particularly the diagnostics accelerator, which aims at identifying a better way to diagnose Alzheimer disease. [WATCH TIME: 6 minutes]
Managing Insomnia: An Overview of Pharmacologic Agents
Shared insight on the pharmacologic treatment landscape of insomnia, with a focus on mainstay drug classes.
When to Initiate Pharmacologic Therapy for Insomnia
Focusing on the pharmacologic setting of insomnia, experts consider when it is best to initiate therapy.
The Development of Technology for Alzheimer Disease: Howard Fillit, MD
January 31st 2022Discussing recent technological advancements in the AD field, the founding executive director of the Alzheimer’s Drug Discovery Foundation noted the doors that these innovations have opened. [WATCH TIME: 4 minutes]
Approaching Post-COVID Cognitive Changes, Milder Cognitive Disorders: Joanna Hellmuth, MD, MS
January 27th 2022The cognitive neurologist at the University of California, San Francisco discussed the complexities in characterizing milder cognitive disorders and the need for more tailored assessments for these patients. [WATCH TIME: 8 minutes]
Using Prior Success to Improve Alzheimer Trials, Drug Development: Jeffrey Cummings, MD, ScD
January 26th 2022The director of the Chambers-Grundy Center for Transformative Neuroscience at the University of Nevada, Las Vegas discussed how the momentum gained within the Alzheimer community can springboard success going forward. [WATCH TIME: 4 minutes]
Conducting Clinical Trials in Pediatric Migraine: Christina Szperka, MD, MSCE
January 25th 2022The director of the Pediatric Headache Program at CHOP spoke on the challenges associated with clinical trials in pediatric migraine, further discussing the biggest advance made amid the COVID-19 pandemic. [WATCH TIME: 6 minutes]
